Literature DB >> 19175855

A novel electrophysiologic effect of melatonin on ischemia/reperfusion-induced arrhythmias in isolated rat hearts.

Emiliano Raúl Diez1, Laura Vanina Prados, Adriana Carrión, Zumino Amira Zulma Ponce, Roberto Miguel Miatello.   

Abstract

Reperfusion after a short period of cardiac ischemia triggers ventricular arrhythmias attributable to ionic imbalance and oxidative stress. Melatonin offers some degree of protection, but its effects on the cardiac action potentials are unknown. We evaluated the effects of 5, 10, 20 and 50 microM melatonin in isolated perfused rat hearts subjected to 10 min of regional ischemia. ECG and membrane potentials were synchronously displayed. After 15 min of reperfusion, total antioxidant capacity (TAC) was determined. Melatonin did not change the ischemic depolarization nor the action potential amplitude depression, but at the end of ischemia the action potential duration (APD) decreased in control and 5 microM melatonin-treated hearts. By contrast, it returned to preischemic levels in hearts given 20 and 50 microM melatonin. Melatonin reduced the incidence of reperfusion arrhythmias from 100% in control to 50% in 5 and 10 microM, to 40% in 20 microM and 30% in 50 microM hearts. TAC values were higher at all melatonin concentrations. We conclude that melatonin reduced the incidence of reperfusion arrhythmias because of its antioxidant effects. In addition, at 20 and 50 microM lengthened APD and promoted an improved protection. This latter effect should be considered when in vivo applications of melatonin are considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175855     DOI: 10.1111/j.1600-079X.2008.00643.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  17 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Natticha Sumneang; Chayodom Maneechote; Busarin Arunsak; Titikorn Chunchai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2022-05-19       Impact factor: 9.261

Review 3.  Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice.

Authors:  Artur Bekała; Włodzimierz Płotek; Dorota Siwicka-Gieroba; Joanna Sołek-Pastuszka; Romuald Bohatyrewicz; Jowita Biernawska; Katarzyna Kotfis; Magdalena Bielacz; Andrzej Jaroszyński; Wojciech Dabrowski
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

4.  Melatonin increases the regularity of cardiac rhythmicity in the Drosophila heart in both wild-type and strains bearing pathogenic mutations.

Authors:  Tricia VanKirk; Evelyn Powers; Harold B Dowse
Journal:  J Comp Physiol B       Date:  2016-07-22       Impact factor: 2.200

Review 5.  Melatonin as a protective agent in cardiac ischemia-reperfusion injury: Vision/Illusion?

Authors:  Puneet Kaur Randhawa; Manish Kumar Gupta
Journal:  Eur J Pharmacol       Date:  2020-08-26       Impact factor: 4.432

Review 6.  Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2018-08-13       Impact factor: 9.261

7.  Acute administration of natural honey protects isolated heart in normothermic ischemia.

Authors:  Afshin Gharekhani; Moslem Najafi; Hamed Ghavimi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

8.  Sleep Medications Containing Melatonin can Potentially Induce Ventricular Arrhythmias in Structurally Normal Hearts: A 2-Patient Report.

Authors:  Lennart J de Vries; Tamas Géczy; Tamas Szili-Torok
Journal:  J Cardiovasc Pharmacol       Date:  2017-10       Impact factor: 3.105

Review 9.  Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.

Authors:  Mohammad Hossein Pourhanifeh; Ehsan Dehdashtian; Azam Hosseinzadeh; Seyed Hashem Sezavar; Saeed Mehrzadi
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

Review 10.  Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use.

Authors:  Ovidiu Constantin Baltatu; Sergio Senar; Luciana Aparecida Campos; José Cipolla-Neto
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.